Treatment Registry
TR-0548 ActiveRecorded September 2, 2026

Compounded semaglutide

Sold by RIVO Health · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$279

Medication · Monthly plan (no annual commitment)$279

Added from the figures recorded below.

Price

TermPer monthCharged today
Monthly plan (no annual commitment)

Starting at $149 /mo $279/mo with an annual plan SAVE 58%

source

Per month$279Charged today$279
Starting price with an annual plan

Starting at $149 /mo $279/mo with an annual plan SAVE 58%

source

Per month$149Charged today$149
Visit RIVO Health

We earn nothing from this link. RIVO Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberLive visit

Not yet checked: pharmacy, states, cancellation, membership and consult fee.

Recorded from rivohealth.co. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026RIVO's plan tiles read 'RIVO™ Signature Plans: Medication + Coaching + Care. Membership included free.' and list 'Fridays™ Membership Included ($O)' — i.e. the care/coaching membership is bundled at no extra cost inside the $149/$199 medication price, the opposite of the exclusion pattern, so the figures are recorded as prices rather than membership. Meaning of the two figures per drug ($149 vs $279, $199 vs $389) is ambiguous from static text — likely an annual-commitment rate vs a month-to-month rate — both are recorded since both dollar amounts sit inside the same quoted sentence. The page explicitly states these are compounded GLP-1s: 'Compounded GLP-1s are produced in FDA-regulated facilities... not FDA-approved or evaluated for safety, efficacy, or quality.' Could not confirm injection-vial vs pen or oral-tablet split, or a states/cancellation policy — the pricing subdomain (pricing.rivohealth.co) failed with a TLS error on every attempt.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0548
Readings
1

Related records

What else RIVO Health sells

All RIVO Health programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 298 records of the same molecule.

Cite this entry

Treatment Registry. (2026). RIVO Health compounded semaglutide (TR-0548). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0548

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.